GLAXOSMITHKLINE AUSTRALIA PTY LTD

ABN: 47100162481BAYSWATER, VIC
Enterprise ($50M+)
+87.3% YoY
$1.5B
Total Value
5
Total Contracts
Drugs and Pharmaceutical
Primary Category

Recent Contracts

Active
Drugs and Pharmaceutical
27 June 2025
CN4164112—Supply of Essential Vaccines to the National Immunisation Program$303.6M

30 June 2025 - 29 June 2026

Department of Health and Aged Care
Expired
Drugs and Pharmaceutical
8 Apr 2025
CN4077601—Supply of Essential Vaccines to the National Immunisation Program$446.1M

30 June 2024 - 29 June 2025

Department of Health and Aged Care
Expired
Drugs and Pharmaceutical
7 Nov 2023
CN3991067—Supply of Essential Vaccines$504.4M

27 July 2023 - 29 June 2024

Department of Health and Aged Care

2 more contracts available

Peer Benchmarking

See how GLAXOSMITHKLINE AUSTRALIA PTY LTD ranks against similar companies in their category and size band.

Financial Year Breakdown

FY25
$749.7M(2 contracts)
FY24
$504.4M(1 contracts)

2 more years available

Unlock full history →

Company Details

Name
GLAXOSMITHKLINE AUSTRALIA PTY LTD
Also known as
GSK Melbourne, STIEFEL, A GSK COMPANY, STIEFEL, A GSK COMPANY +6 more
Entity Type
Australian Private Company
ABN
47 100 162 481
Town/City
BAYSWATER
Postcode
3153
State/Territory
VIC
Country
Australia